About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘springer retractions’ Category

Failure to disclose drug company sponsor among litany of reasons for cancer retraction

leave a comment »

tumor biologyThis one’s a real mess.

In June, a paper in Tumor Biology was retracted for at least four reasons, including bad data and hiding a trial sponsor (Merck). Some people who contributed work weren’t cited; at least one author had no idea his name would be on it. And that’s just what they tell us in the notice.

Here’s the notice for “Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China:” Read the rest of this entry »

About these ads

Ripping off someone else’s thesis sinks paper on chicken temperatures

with 5 comments

ISB_IJBProof that people will plagiarize anything they think they can get away with: a Brazilian scientist plagiarized a masters’ student’s thesis on the surface temperature of chickens.

We spoke with International Journal of Biometeorology editor-in-chief Scott Sheridan about the case: Read the rest of this entry »

Written by Cat Ferguson

October 14, 2014 at 9:30 am

Asthma study yanked for serious ethical violations

with 11 comments

springerplusA paper in SpringerPlus on treating asthma with antioxidants was retracted on September 25 for something of a trifecta of ethical problems.

The retraction notice indicates that the patients never consented, there was no ethical review, and the university supposedly overseeing the study had no knowledge of it:

Read the rest of this entry »

Written by Cat Ferguson

October 13, 2014 at 9:30 am

Yet another study of widely touted cancer “cure” retracted

with 7 comments

cancer immunology immunotherapyA third study of GcMAF, a protein being used to treat a variety of conditions from AIDS to autism to cancer, all without the blessing of health agencies, has been retracted.

Here’s the notice in Cancer Immunology, Immunotherapy for “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF:” Read the rest of this entry »

Journal makes it official, retracting controversial autism-vaccine paper

with 17 comments

translational neurodegenerationA little more than a month after removing a highly criticized article that claimed the measles-mumps-rubella (MMR) vaccine increased the risk of autism in African American boys, Translational Neurodegeneration has officially retracted the paper.

Here’s the notice, dated yesterday: Read the rest of this entry »

Author of alcohol paper retracted for plagiarism defends copy-and-paste strategy

with 9 comments

nmlogoThe authors of a paper retracted for plagiarism of a popular website have decided not to take the charges — which they don’t contest — lying down.

Here’s the notice for “Alcohol consumption and hormonal alterations related to muscle hypertrophy: a review,” which appeared in Nutrition & Metabolism, a BioMed Central title: Read the rest of this entry »

Written by Ivan Oransky

September 30, 2014 at 9:30 am

It’s happened again: Researcher appears to have peer reviewed his own paper

with 2 comments

bmc sys bioAlthough it shocks some observers every time, we’ve reported on the retractions of more than 100 papers pulled because authors managed to do their own peer review.

Apparently, it’s happened again.

Here’s a retraction notice in BMC Systems Biology for “Predicting new molecular targets for rhein using network pharmacology,” by  Aihua Zhang, Hui Sun, Bo Yang and Xijun Wang:

Read the rest of this entry »

Written by Ivan Oransky

September 29, 2014 at 11:31 am

Follow

Get every new post delivered to your Inbox.

Join 35,810 other followers